首页> 外文期刊>Abdominal radiology. >Outcome of liver lesions indeterminate for malignancy on ultrasound: the role of patient age, risk status, and lesion echogenicity
【24h】

Outcome of liver lesions indeterminate for malignancy on ultrasound: the role of patient age, risk status, and lesion echogenicity

机译:肝脏病变的结果不确定对超声波的恶性肿瘤:患者年龄,风险状况和病变回声的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: The purpose of this study was to evaluate the relationship between final outcome of lesions indeterminate for malignancy on ultrasound (US) and patient and imaging characteristics. Methods: We identified all patients with indeterminate liver lesions on US between 9/1/2013 and 12/31/2014 using institutional codes based on radiologist opinion. Miscoded lesions (n = 30) and patients with no imaging, pathology, or clinical follow-up at our health system (n = 6) were excluded. Final diagnostic category of malignant, benign, pseudolesion, or indeterminate was assigned using imaging, pathology, and clinical follow-up. Differences in diagnostic categories were compared by patient (age, gender, race, known malignancy. or liver disease) and imaging characteristics (lesion size, echogenicity. and number). Independent likelihood of a benign final diagnostic category was adjusted for significant variables on univariate analysis. Results: Indeterminate liver lesions on US were found in 153/6813 patients (2%). Final diagnostic categories were malignant (11/153, 7%), benign (94/153, 61%), pseudolesion (42/153, 27%). and indeterminate (6/153, 4%). Nearly one-third of hypoechoic masses in patients with known malignancy or liver disease (i.e., high-risk status) > 46 years of age were malignant (9/28, 32%). On multivariate analysis, patients of age > 61 years and high-risk status were associated with decreased likelihood of benign diagnostic category (OR .19 (95% CI .07-.51) and OR .40 (95% CI .18-.88), p values .001 and .022, respectively). Conclusions: 2% of patients undergoing abdominal US have sonographically indeterminate liver lesions, of which 7% are malignant. Older, high-risk patients with hypoechoic lesions should receive short-term follow-up as one-third will have malignant lesions. Younger, low-risk patients should receive conservative follow-up, regardless of US imaging features.
机译:目的:本研究的目的是评估病变的最终结果与患者和患者和成像特征的恶性肿瘤不确定的关系。方法:使用基于放射科师的机构代码在9/1/1013和2014年12月1日至2014年至2014年至2014年间,鉴定了所有患有不确定肝病变的患者。不包括在卫生系统(n = 6)的成像,病理学或临床后续的误诊(n = 30)和患者被排除在外。使用成像,病理学和临床随访分配最终的恶性,良性,伪或不确定的恶性,良性,伪或不确定的诊断类别。通过患者(年龄,性别,种族,已知恶性肿瘤或肝脏疾病)和成像特征(病变大小,回声和数量)进行诊断类别的差异。调整了良性最终诊断类别的独立可能性,以实现单变量分析的重大变量。结果:153/6813名患者(2%)发现了美国的肝脏病变。最终的诊断类别是恶性的(11/153,7%),良性(94/153,61%),伪(42/153,27%)。并保留(6/153,4%)。已知恶性肿瘤或肝病(即高危地位)> 46岁的患者中近三分之一的乳头肿块是恶性(9/28,32%)。在多变量分析中,年龄> 61岁患者和高风险状态与良性诊断类别的可能性降低有关(或.19(95%CI.07-.51)和或.40(95%CI.18-。 88),P值分别为0.001和.022)。结论:2%的接受腹部患者的患者具有同步性不确定的肝脏病变,其中7%是恶性的。较旧的,高风险的低风险患者的低压病变应接受短期随访,因为三分之一将具有恶性病变。年轻,低风险的患者应获得保守的随访,无论我们的成像功能如何。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号